I’m James Black, director for Roche’s late-stage Insights codebase and business lead for our clinical and RWD scientific computing environment environments. Previously, I was studying at the MRC Epidemiology Unit/Jesus College, University of Cambridge, worked at the London School of Hygiene and Tropical Medicine, and did my earlier degrees and schooling in New Zealand.
PhD in Medical Science, 2015
MPhil in Epidemiology, 2012
Masters in Public Health, 2010
BBioMedSci in Infection & Immunity, 2008
Type 2 diabetes increases an individual’s risk of Cardiovascular Disease (CVD). Trials have demonstrated the long term macro-vascular benefits of lowering glucose, as well as other CVD risk factors, in populations with established diabetes.